This inventor holds 1 USPTO granted patent. Top assignees: Peri Development Applications (1985) Ltd., Rhone-Poulenc Rorer Pharmaceuticals Inc.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: David R Hurwitz: Innovator in Human Serum Albumin Expression Constructs
Introduction
David R Hurwitz is an accomplished inventor based in Wyndmoor, PA (US). He is known for his significant contributions to the field of biotechnology, particularly in the development of DNA constructs for human serum albumin expression.
Latest Patents
Hurwitz holds a patent for a "Human serum albumin expression construct." This invention provides DNA constructs that include a promoter DNA sequence and a DNA sequence coding for human serum albumin. In one embodiment, the human serum albumin sequence comprises at least one, but not all, of the introns found in the naturally occurring gene encoding for the HSA protein. Additionally, the DNA constructs may include a 5' regulatory sequence that directs the expression and secretion of HSA protein in the milk of a transgenic animal. Preferably, the promoter gene is a milk protein promoter sequence such as β-lactoglobulin. The invention also encompasses transgenic animals that secrete HSA in the milk of lactating females, as well as vectors that comprise the constructs.
Career Highlights
Throughout his career, Hurwitz has worked with notable companies, including Rhone-Poulenc Rorer Pharmaceuticals Inc. and Peri Development Applications (1985) Ltd. His work has significantly impacted the biotechnology sector, particularly in the area of protein expression.
Collaborations
Hurwitz has collaborated with esteemed colleagues, including Margret Nathan and Moshe Shani, contributing to advancements in his field.
Conclusion
David R Hurwitz is a notable inventor whose work in human serum albumin expression constructs has made a lasting impact on biotechnology. His innovative approaches continue to influence the development of transgenic animals and protein expression technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile